Capital Group Private Client Services’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-115,021	Closed	-$9.8M	–	243
2021 Q4	$9.8M	Sell	115,021 -4,864	-4%	-$414K	0.1%	132
2021 Q3	$11.5M	Buy	+119,885	New	+$11.5M	0.13%	125